3-Bromo-2-chloro-4-(difluoromethoxy)pyridine

Catalog No.: 
ACAEYG458
CAS No.: 
1805137-37-4
Molecular Formula: 
C6H3BrClF2NO
Molecular Weight: 
258.45
3-Bromo-2-chloro-4-(difluoromethoxy)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$96.00In stockInquiry
1g95%$258.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-2-chloro-4-(difluoromethoxy)pyridine
IUPAC Name3-bromo-2-chloro-4-(difluoromethoxy)pyridine
MDL No.MFCD28733844
Molecular FormulaC6H3BrClF2NO
Molecular Weight258.45
SMILESFC(F)OC1=C(Br)C(Cl)=NC=C1
InChI KeyIGPNMARLFKSZIS-UHFFFAOYSA-N
Synonym3-Bromo-2-chloro-4-(difluoromethoxy)pyridine;Pyridine, 3-bromo-2-chloro-4-(difluoromethoxy)-
CAS No.1805137-37-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAEYG458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAEMV397 route compound structure diagram
    ACAEMV3971211519-66-2In Stock
  4. Then
  5. ACAEYG458 route product structure diagram
    ACAEYG4581805137-37-4In Stock
Inquiry

2. ACAEYG458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQFCD671 route compound structure diagram
    ACQFCD671144584-32-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEYG458 route product structure diagram
    ACAEYG4581805137-37-4In Stock
Inquiry

3. ACAEYG458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEYG458 route product structure diagram
    ACAEYG4581805137-37-4In Stock
Inquiry

Comments (0)